#166 of 500 · Foundation / Grantmaker / DAF

Glaxosmithkline Patient Access Programs Foundation

EIN 20-0031992 · PA · NTEE T23 · Form 990-PF, fiscal 2023

An independent 501(c)(3) charitable foundation based in Philadelphia, Pennsylvania. It administers patient-assistance programs that provide GSK and ViiV Healthcare prescription medicines and certain vaccines at no cost to eligible patients in the United States who cannot afford them. It charges no fees to apply for or receive medication assistance.

Financials, fiscal 2023

Revenue

$903.0M

Expenses

$903.0M

Total assets

$73.5M

Net assets

$1

Operating margin

0.0%

1-year growth

15.0%

5-year growth (CAGR)

16.7%

Reserve (years of spending)

0.0

Contributions share

100.0%

Programme spending

n/a

Fundraising cost

n/a

Executive pay share

0.00%

Employees

n/a

Revenue per employee

n/a

Grants paid

n/a

Years filing

19

NFP Health Score: 52 / 100

Financial 17 · Governance 85 · Operational 90. The score is built from Form 990 line items only. It cannot measure how well an organisation delivers its mission.

Revenue history